ROCHESTER, NY – Bio-Optronics, makers of the industry-leading Clinical Conductor® CTMS, is pleased to unveil three new products as part of CCTrialSuite®, the industry’s most comprehensive set of seamlessly-integrated, patient-centric clinical research management products. The additions to CCTrialSuite® are:
CCeSource® – A comprehensive eSource system designed to capture source data in real time, enhance data quality and optimize site operations.
CCeReg® – A superior eRegulatory document management product that allows sites to eliminate paper binders and provides an efficient document management system for managing complex regulatory requirements.
CCeConsent® – The industry’s first site-focused electronic informed consent application that ensures regulatory compliance, empowers patient understanding and eliminates unnecessary study delays.
“The addition of these eClinical applications to CCTrialSuite® affirms our unique approach solving complex life sciences problems that has made Bio-Optronics an industry leader in clinical research software for the past twelve years” states Laku Adedoyin, CTO at Bio-Optronics. “We are pleased to offer this unprecedented level of value to the research community through flexible solution offerings that align to the business and clinical needs for research sites, networks, hospitals and health systems.”
Bio-Optronics announced CCTrialSuite® in April 2019 with two new products, CCPay® and CCText®, along with CC CTMS® (formerly Clinical Conductor®). Bio-Optronics is also showcasing the full CCTrialSuite® solution at the 2019 Site Solutions Summit in Ft. Lauderdale, FL.
Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance. With applications focused on clinical research, automated resource utilization and patient safety, Bio-Optronics software is used by thousands of healthcare organizations worldwide to simplify complex business processes and enhance overall quality and efficiency.